Optimizing Cardiovascular Treatment in Non-Small Cell Lung Cancer: A Comprehensive Computational Approach for Assessment of Drug-Drug Interactions Between Tyrosine Kinase Inhibitors and Cardiovascular Drugs [version 2; peer review: 2 approved, 1 approved with reservations]
Background As lung cancer treatment has progressed, there has been an increase in awareness of the short- and long-term adverse effects of targeted cancer therapies of tyrosine kinase inhibitors, particularly cardiovascular toxicities. Methods The current study assessed the potential drug-drug inter...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
F1000 Research Ltd
2025-10-01
|
| Col·lecció: | F1000Research |
| Matèries: | |
| Accés en línia: | https://f1000research.com/articles/14-309/v2 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|